Cytori Reports Second Quarter 2015 Business and Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/22/2026
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Applied Optoelectronics sets up $600M at-the-market stock offering
- Fannie Mae loses at least 10 senior executives amid departures - WSJ
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- Morgan Stanley course-corrects their semiconductor equipment outlook on demand
- One killed, three injured when man attacks Swedish school with sword
Roth Capital Cuts Price Target on Cytori Therapeutics (CYTX) Following 2Q Earnings Report
August 10, 2015 7:56 AM EDTRoth Capital reiterated a Buy rating on Cytori Therapeutics, Inc. (NASDAQ: CYTX), and cut the price target to $4.00 (from $6.00), following the company's 2Q15 earnings release. EPS of $0.03 beat the consensus estimates of -$0.03. CYTX ended the quarter with $23.8 million in cash.
Analyst Joseph Pantginis... More
Cytori Therapeutics (CYTX) PT Trimmed to $5 at Maxim Group; 'Buy' Maintained
August 7, 2015 7:43 AM EDTMaxim Group analyst Jason Kolbert trimmed his price target on Cytori Therapeutics, Inc. (NASDAQ: CYTX) to $5.00 (from $7.00) following Q2 results but maintained his Buy rating.
The cut comes on a greater than expected share count.
The analyst highlighted the following Quarter Progress: STAR TRIAL, OA, Incontinence and Burns
Announced the launch of its US STAR trial, which is being considered a "pivotal"... MoreCytori Therapeutics (CYTX) Tops Q2 EPS by 6c
August 6, 2015 4:38 PM EDTCytori Therapeutics (NASDAQ: CYTX) reported Q2 EPS of $0.03, $0.06 better than the analyst estimate of ($0.03). Revenue for the quarter came in at $1.61 million versus the consensus estimate of $2.5 million.
For earnings history and earnings-related data on Cytori Therapeutics (CYTX) click here.
... More